Are you ready? EU’s Clinical Trials Regulation and portal goes live 31 January
The EU’s Clinical Trials Regulation and information system aims to streamline applications and bolster transparency – but initial rollout could…
By
Pharma Insights
Latest in
Pharma Insights
Long Covid-19: drug trial results to watch in 2022
At least four long Covid-19 drug trial readouts are expected in 2022 that could shape the future of the therapeutic…
By
Pipeline Moves: Pfizer completes Phase I trial, boosts NASH program
iOnctura’s and Blade’s respective assets in idiopathic pulmonary fibrosis are also reviewed by Clinical Trials Arena.
By
Pipeline Moves: J&J ends ulcerative colitis trial, further study chances drop
Clinical Trials Arena reviews a total of six trials, including ones in gram-negative bacterial infections, hepatitis B, and obesity.
By
Clinical trial diversity: It’s time to quit talking and start doing
In order to improve diversity in trials, inequities due to economic factors and race need to be bridged at institutional…
By
Pipeline Moves: GSK’s likelihood of further study in tuberculosis rises
Stuart Therapeutics in dry eye disease and Vifor Pharma in beta thalassemia are also reviewed by Clinical Trials Arena.
By
ALS: drug trial results to watch in 2022
Pharma companies are pouring more efforts into ALS studies, setting the stage for several major drug trial readouts this year.
By
Timing of Synairgen Phase III nebulised Covid-19 treatment remains a challenge
There are also concerns surrounding Synairgen SNG001’s potential inflammatory effects in advanced Covid-19.
By